198 related articles for article (PubMed ID: 23418309)
1. Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas.
Wang Y; He X; Yu Q; Eng C
Hum Mol Genet; 2013 Jun; 22(11):2263-72. PubMed ID: 23418309
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.
Wang Y; Radhakrishnan D; He X; Peehl DM; Eng C
J Clin Endocrinol Metab; 2013 Mar; 98(3):E586-94. PubMed ID: 23386643
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas.
Du CW; Kimijima I; Otake T; Abe R; Takenoshita S; Zhang GJ
Chin Med J (Engl); 2011 Aug; 124(15):2275-8. PubMed ID: 21933556
[TBL] [Abstract][Full Text] [Related]
4. Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation.
Wang Y; Yu Q; He X; Romigh T; Altemus J; Eng C
Mol Cancer Ther; 2014 Feb; 13(2):517-27. PubMed ID: 24356815
[TBL] [Abstract][Full Text] [Related]
5. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
Nizialek EA; Peterson C; Mester JL; Downes-Kelly E; Eng C
Hum Mol Genet; 2013 Jun; 22(12):2451-61. PubMed ID: 23446638
[TBL] [Abstract][Full Text] [Related]
6. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C
Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
9. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
10. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
[TBL] [Abstract][Full Text] [Related]
12. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
13. Physical and functional interaction between p53 mutants and different isoforms of p73.
Strano S; Munarriz E; Rossi M; Cristofanelli B; Shaul Y; Castagnoli L; Levine AJ; Sacchi A; Cesareni G; Oren M; Blandino G
J Biol Chem; 2000 Sep; 275(38):29503-12. PubMed ID: 10884390
[TBL] [Abstract][Full Text] [Related]
14. PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.
Tschan MP; Reddy VA; Ress A; Arvidsson G; Fey MF; Torbett BE
Oncogene; 2008 May; 27(24):3489-93. PubMed ID: 18193090
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73, and induces cell cycle block and apoptosis in human promonocytic U937 cells.
Hanks TS; Gauss KA
Apoptosis; 2012 Mar; 17(3):236-47. PubMed ID: 22076304
[TBL] [Abstract][Full Text] [Related]
17. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.
Wang Y; He X; Ngeow J; Eng C
Hum Mol Genet; 2012 Feb; 21(3):569-76. PubMed ID: 22021428
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
19. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
Zhu A; Li Y; Song W; Xu Y; Yang F; Zhang W; Yin Y; Guan X
Cell Physiol Biochem; 2016; 38(3):1003-14. PubMed ID: 26938985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
